Download PDF
Semin Respir Crit Care Med 2012; 33(06): 645-652
DOI: 10.1055/s-0032-1326962
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Asthma Phenotypes

Ian D. Pavord
1   Department of Respiratory Medicine, Thoracic Surgery, and Allergy, Institute for Lung and Health, Glenfield Hospital, Leicester, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
09 October 2012 (online)

    Permissions and Reprints

Abstract

The identification of phenotypes of asthma has a long history, but previous classifications have not identified clinically important differences in pathology, natural history, or treatment response. Progress has accelerated recently, fueled by the development of new techniques to assess airway disease, particularly noninvasive techniques to assess airway inflammation. This article discusses evidence that a simple subdivision of patients into eosinophilic and noneosinophilic asthma is clinically important because it identifies groups with markedly different responses to corticosteroids and other drugs that manipulate the Th-2 (T-helper) pathway. All classification systems suffer from potential bias given that different disease variables are subjectively weighted. There has been increasing interest in the application of mathematical techniques such as factor analysis and cluster analysis to organize and group large amounts of interrelated data in an unbiased way. This article discusses attempts to do this in asthma and speculates on the clinical implications of this new information.

Keywords

asthma - phenotypes - eosinophilic asthma - noneosinophilic asthma
 

  • References

  • 1 Rackemann FM. A clinical survey of 1074 patients with asthma followed for two years. J Lab Clin Med 1927; 12: 1185-1197
    PubMedGoogle Scholar
  • 2 Marsh SE, Travers J, Weatherall M , et al. Proportional classifications of COPD phenotypes. Thorax 2008; 63 (9) 761-767
    CrossrefPubMedGoogle Scholar
  • 3 Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002; 57 (10) 875-879
    CrossrefPubMedGoogle Scholar
  • 4 Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95 (4) 843-852
    CrossrefPubMedGoogle Scholar
  • 5 Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 2007; 62 (3) 211-218
    CrossrefPubMedGoogle Scholar
  • 6 Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353 (9171) 2213-2214
    CrossrefPubMedGoogle Scholar
  • 7 Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest 2001; 120 (6) 1917-1922
    CrossrefPubMedGoogle Scholar
  • 8 Haldar P, Pavord ID, Shaw DE , et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178 (3) 218-224
    CrossrefPubMedGoogle Scholar
  • 9 Bougault V, Turmel J, St-Laurent J, Bertrand M, Boulet LP. Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes. Eur Respir J 2009; 33 (4) 740-746
    CrossrefPubMedGoogle Scholar
  • 10 Anees W, Huggins V, Pavord ID, Robertson AS, Burge PS. Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax 2002; 57 (3) 231-236
    CrossrefPubMedGoogle Scholar
  • 11 Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol 2007; 119 (5) 1043-1052 , quiz 1053–1054
    CrossrefPubMedGoogle Scholar
  • 12 Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008; 177 (2) 148-155
    CrossrefPubMedGoogle Scholar
  • 13 Brightling CE, Ward R, Goh KL, Wardlaw AJ, Pavord ID. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999; 160 (2) 406-410
    CrossrefPubMedGoogle Scholar
  • 14 Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989; 1 (8651) 1346-1348
    PubMedGoogle Scholar
  • 15 Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 2005; 35 (10) 1254-1262
    CrossrefPubMedGoogle Scholar
  • 16 Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J Allergy Clin Immunol 1999; 103 (2 Pt 1) 232-237
    CrossrefPubMedGoogle Scholar
  • 17 Moore WC, Meyers DA, Wenzel SE , et al; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181 (4) 315-323
    CrossrefPubMedGoogle Scholar
  • 18 American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000; 162 (6) 2341-2351
    CrossrefPubMedGoogle Scholar
  • 19 Green RH, Brightling CE, McKenna S , et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360 (9347) 1715-1721
    CrossrefPubMedGoogle Scholar
  • 20 Jayaram L, Pizzichini MM, Cook RJ , et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006; 27 (3) 483-494
    CrossrefPubMedGoogle Scholar
  • 21 Pavord ID, Birring SS, Berry M, Green RH, Brightling CE, Wardlaw AJ. Multiple inflammatory hits and the pathogenesis of severe airway disease. Eur Respir J 2006; 27 (5) 884-888
    PubMedGoogle Scholar
  • 22 Pavord ID, Wardlaw AJ. The A to E of airway disease. Clin Exp Allergy 2010; 40 (1) 62-67
    PubMedGoogle Scholar
  • 23 Cox G, Thomson NC, Rubin AS , et al; AIR Trial Study Group. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007; 356 (13) 1327-1337
    CrossrefPubMedGoogle Scholar
  • 24 Chaudhuri R, Livingston E, McMahon AD , et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174 (2) 127-133
    CrossrefPubMedGoogle Scholar
  • 25 Sovani MP, Whale CI, Oborne J , et al. Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?. Br J Gen Pract 2008; 58 (546) 37-43
    CrossrefPubMedGoogle Scholar
  • 26 Leckie MJ, ten Brinke A, Khan J , et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356 (9248) 2144-2148
    CrossrefPubMedGoogle Scholar
  • 27 Djukanović R, Wilson SJ, Kraft M , et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2004; 170 (6) 583-593
    CrossrefPubMedGoogle Scholar
  • 28 Wark PA, Hensley MJ, Saltos N , et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111 (5) 952-957
    CrossrefPubMedGoogle Scholar
  • 29 Geraci C, Longo G. Anti-IgE for asthma in inner-city children. (letter) N Engl J Med 2011; 364 (26) 2557-2558, author reply 2557–2558
    PubMedGoogle Scholar
  • 30 Haldar P, Brightling CE, Hargadon B , et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360 (10) 973-984
    CrossrefPubMedGoogle Scholar
  • 31 Nair P, Pizzichini MM, Kjarsgaard M , et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360 (10) 985-993
    CrossrefPubMedGoogle Scholar
  • 32 Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346 (22) 1699-1705
    CrossrefPubMedGoogle Scholar
  • 33 Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003; 167 (10) 1360-1368
    CrossrefPubMedGoogle Scholar
  • 34 Berry MA, Hargadon B, Shelley M , et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006; 354 (7) 697-708
    CrossrefPubMedGoogle Scholar
  • 35 Jatakanon A, Lalloo UG, Lim S, Chung KF, Barnes PJ. Increased neutrophils and cytokines, TNF-alpha and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough. Thorax 1999; 54 (3) 234-237
    CrossrefPubMedGoogle Scholar
  • 36 Birring SS, Brightling CE, Symon FA, Barlow SG, Wardlaw AJ, Pavord ID. Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis. Thorax 2003; 58 (12) 1066-1070
    CrossrefPubMedGoogle Scholar
  • 37 Birring SS, Parker D, Brightling CE, Bradding P, Wardlaw AJ, Pavord ID. Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med 2004; 169 (1) 15-19
    CrossrefPubMedGoogle Scholar
  • 38 Brightling CE, Pavord ID. Eosinophilic bronchitis: an important cause of prolonged cough. Ann Med 2000; 32 (7) 446-451
    CrossrefPubMedGoogle Scholar
  • 39 Hogg JC, Chu F, Utokaparch S , et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350 (26) 2645-2653
    CrossrefPubMedGoogle Scholar
  • 40 Fishman A, Martinez F, Naunheim K , et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348 (21) 2059-2073
    CrossrefPubMedGoogle Scholar